Streptozotocin can interfere with the function of the beta cells of the islets of Langerhans, resulting in inhibition of insulin release, which in turn leads to hyperglycemia and diabetic complications like diabetic cardiomyopathy [6, 16]. This evidence concerns the gene INS and diabetic cardiomyopathy.